Specifically, the atrophy trajectory among AQP4 + NMOSD patients across various atrophy subtypes sheds light on potential patterns of disease progression, offering a novel perspective for understanding the subtle brain tissue damage in AQP4 + NMOSD patients [10, 53]. Here, AQP4 is linked to Atrophy.